Schrodinger reported the appointment of veteran pharmaceutical executive Joel Lebowitz as chief financial officer. Before joining Schrodinger, Lebowitz spent Merck, serving most recently as global finance lead, project management. In that role, he led a global finance team in the successful divestiture of the Merck Consumer Care division. He also spent three years as Merck's executive director for pipeline valuation and portfolio analysis.